The incidence and type of allergic reactions to antilymphoblast globulin (ALG) and their relationship to skin testing, histamine release, and serum levels of ALG and anti-ALG antibodies were studied prospectively in 50 patients receiving high-dose ALG therapy intravenously for the first two weeks after renal transplantation. No clinically apparent allergic reactions occurred in the patients studied.
|Original language||English (US)|
|Number of pages||3|
|Journal||JAMA: The Journal of the American Medical Association|
|State||Published - Oct 11 1976|